TDAG51 and Its Role in Breast Cancer Cell Transformation
Author Information
Author(s): Michael D. Oberst, Stacey J. Beberman, Liu Zhao, Juan Juan Yin, Yvona Ward, Kathleen Kelly
Primary Institution: Cell and Cancer Biology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health
Hypothesis
Which signal transduction pathways downstream of Ras contribute to EGFR-dependent transformation of mammary epithelial cells?
Conclusion
The study suggests that the ERK signaling pathway is crucial for mammary epithelial cell transformation and that TDAG51 acts as a negative regulator of this process.
Supporting Evidence
- Activation of both the ERK and PI3K signaling pathways was sufficient to induce cellular transformation.
- Only activation of the ERK pathway was sufficient to transform cells in the presence of EGFR inhibition.
- Knockdown of TDAG51 resulted in increased ERK pathway activation and enhanced proliferation of transformed cells.
Takeaway
This study found that a protein called TDAG51 helps control how breast cells grow and can stop them from becoming cancerous when they are not attached to a surface.
Methodology
The study used anchorage-independent growth assays and shRNA to investigate the role of TDAG51 in mammary epithelial cell transformation.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website